INSIGHTS ON DRUG DEVELOPMENT

  • Emulate Endorses The FDA Modernization Act Of 2021
    5/10/2024

    Learn why removing the mandate for animal testing would enable faster, more efficient, and more humane drug development, all while benefiting both patients and the pharmaceutical industry.

  • Ready To Demystify Organoids?
    7/1/2025

    Organoids are transforming biomedical research. Explore their top applications, research workflows, key challenges, and dissociation techniques in this comprehensive guide to personalized medicine.

  • CRISPR Meets LNPs: A New Era In Cell And Gene Therapies
    7/8/2025

    Explore how lipid nanoparticles are revolutionizing non-viral gene editing with scalable, efficient delivery for both ex vivo and in vivo applications, which features new CRISPR-LNP data in T cells.

  • Modeling Colorectal Cancer Progression
    8/2/2024

    Gain a better understanding of the microenvironment's role in colorectal cancer progression by reviewing the integration of Organ-Chip models with high-content imaging and mass spectrometry-based metabolomics.

  • Scale Your Viral Vector Production With A Streamlined Bioreactor System
    11/4/2025

    Scale your viral vector or vaccine production with a streamlined, intermediate-scale bioreactor system that bridges development and commercial manufacturing, supporting applications from exosomes to vaccines.

DRUG DEVELOPMENT SOLUTIONS

  • In silico modeling technologies are transforming drug development and manufacturing by enhancing efficiency, accuracy, to allow innovations.

  • Learn how tailored lipids, polymers, and carbohydrate‑based materials strengthen targeted delivery, enhance stability, and support scalable development for emerging therapeutic modalities.

  • Integrated lab services deliver method development, validation, and testing across modalities, supporting quality, compliance, and formulation progress from early development to commercialization.

  • Enhance your research and obtain exceptional imaging and analysis with a configurable and upgradeable high-content screening system that captures high-definition images and robust data from 2D and 3D assays.

  • Backed by trusted data and deep scientific expertise, learn how our adaptive approach ensures seamless progression from preclinical development to commercial manufacturing.